+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteoarthritis Drug"

From
Osteoarthritis Therapeutics: Global Markets 2021-2026 - Product Thumbnail Image

Osteoarthritis Therapeutics: Global Markets 2021-2026

  • Report
  • January 2022
  • 133 Pages
  • Global
From
From
From
Osteoarthritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Osteoarthritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Erosive Hand Osteoarthritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Erosive Hand Osteoarthritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Market Spotlight: Osteoarthritis and Osteoarthritis Pain - Product Thumbnail Image

Market Spotlight: Osteoarthritis and Osteoarthritis Pain

  • Report
  • February 2021
  • 48 Pages
  • Global
Market Spotlight: Osteoarthritis - Product Thumbnail Image

Market Spotlight: Osteoarthritis

  • Report
  • June 2018
  • 41 Pages
  • Global
From
Global Osteoarthritis Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Osteoarthritis Therapeutics Market 2023-2027

  • Report
  • January 2023
  • 175 Pages
  • Global
From
US Osteoarthritis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Osteoarthritis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
Loading Indicator

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs). The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more